Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.50 ($0.02), with a volume of 2272402 shares traded. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Trading Down 9.1 %
The firm has a market capitalization of £5.91 million, a P/E ratio of -2,093.22 and a beta of 0.38. The firm has a 50 day moving average price of GBX 1.77 and a 200-day moving average price of GBX 1.85.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
See Also
- Five stocks we like better than Cizzle Biotechnology
- Insider Trading – What You Need to Know
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Profit From Value Investing
- Qualcomm Stock Is Coiling for a Breakout
- How to Find Undervalued Stocks
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
